Waltham, MA-based Thermo Fisher Scientific (NYSE: [[ticker:TMO]]), a provider of products and services for scientific research labs, will buy all outstanding shares of Dionex, for a total of $2.1 billion in cash, the companies announced today. Thermo will pay $118.50 per share for Sunnyvale, CA-based Dionex (NASDAQ: [[ticker:DNEX]]), a maker of liquid chromatography and sample preparation technology, which will be integrated into Thermo’s Analytical Technologies Segment. The deal represents a 21 percent premium over Dionex’s closing stock price on Friday, and is expected to close first quarter of 2011, the companies said.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
